However, in the elderly suffering from COVID-19 or other diseases, the increased circulating inflammatory cytokines and age-associated epigenetic dysregulation preclude this downregulation or even lead to ACE2 upregulation, finally causing worse clinical outcomes. The gene discussed is ACE2; the disease is COVID-19.